Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Darrow

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|April 29, 1994
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell linesA L Cox, J Skipper, Y Chen, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.
Cancer Research|May 15, 1996
Dual recognition of a human cytotoxic T-cell clone for melanoma antigensH Kubo, J Abe, F Obata, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigensC L Slingluff, T A Colella, L Thompson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|April 29, 1994
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell linesA L Cox, J Skipper, Y Chen, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.
Cancer Research|May 15, 1996
Dual recognition of a human cytotoxic T-cell clone for melanoma antigensH Kubo, J Abe, F Obata, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigensC L Slingluff, T A Colella, L Thompson, et al.
Pageof 4